171 related articles for article (PubMed ID: 20031587)
1. Letter by Sullivan regarding article, "HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: the hemochromatosis and iron overload screening study".
Sullivan JL
Circ Cardiovasc Genet; 2009 Jun; 2(3):e1. PubMed ID: 20031587
[No Abstract] [Full Text] [Related]
2. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
[TBL] [Abstract][Full Text] [Related]
3. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
[TBL] [Abstract][Full Text] [Related]
4. HFE hemochromatosis: influence of dietary iron intake on the iron overload of C282Y homozygous patients.
Saliou P; Le Gac G; Mérour MC; Tripogney C; Chanu B; Gourlaouen I; Nousbaum JB; Férec C; Scotet V
Ann Hematol; 2015 Jul; 94(7):1225-7. PubMed ID: 25740382
[No Abstract] [Full Text] [Related]
5. Hemochromatosis, HFE C282Y homozygosity, and polycystic ovary syndrome: report of two cases and possible effects of androgens and hepcidin.
Barton JC; Barton JC
Acta Haematol; 2011; 126(3):138-40. PubMed ID: 21701160
[No Abstract] [Full Text] [Related]
6. [HFE hemochromatosis: pathogenic and diagnostic approach].
Brissot P; Le Lan C; Troadec MB; Lorho R; Ropert M; Lescoat G; Loréal O
Transfus Clin Biol; 2005 Jun; 12(2):77-82. PubMed ID: 15925529
[TBL] [Abstract][Full Text] [Related]
7. Metabolic alterations, HFE gene mutations and atherogenic lipoprotein modifications in patients with primary iron overload.
Meroño T; Brites F; Dauteuille C; Lhomme M; Menafra M; Arteaga A; Castro M; Saez MS; Ballerga EG; Sorroche P; Rey J; Lesnik P; Sordá JA; Chapman MJ; Kontush A; Daruich J
Clin Sci (Lond); 2015 May; 128(9):609-18. PubMed ID: 25442240
[TBL] [Abstract][Full Text] [Related]
8. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
Barton JC; Wiener HW; Acton RT; Go RC
Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
[TBL] [Abstract][Full Text] [Related]
9. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening.
Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; Eckfeldt JH; McLaren CE; Reiss JA; McLaren GD; Reboussin DM; Gordeuk VR; Speechley MR; Press RD; Dawkins FW;
Am J Hematol; 2008 Feb; 83(2):126-32. PubMed ID: 17726683
[TBL] [Abstract][Full Text] [Related]
11. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
[TBL] [Abstract][Full Text] [Related]
12. Multifactorial iron man.
Robson KJ; Drakesmith H
Digestion; 2005; 72(1):22-4. PubMed ID: 16103672
[No Abstract] [Full Text] [Related]
13. Hereditary hemochromatosis--a new look at an old disease.
Pietrangelo A
N Engl J Med; 2004 Jun; 350(23):2383-97. PubMed ID: 15175440
[No Abstract] [Full Text] [Related]
14. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
Merryweather-Clarke AT; Cadet E; Bomford A; Capron D; Viprakasit V; Miller A; McHugh PJ; Chapman RW; Pointon JJ; Wimhurst VL; Livesey KJ; Tanphaichitr V; Rochette J; Robson KJ
Hum Mol Genet; 2003 Sep; 12(17):2241-7. PubMed ID: 12915468
[TBL] [Abstract][Full Text] [Related]
15. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels.
van Dijk BA; Laarakkers CM; Klaver SM; Jacobs EM; van Tits LJ; Janssen MC; Swinkels DW
Br J Haematol; 2008 Sep; 142(6):979-85. PubMed ID: 18557745
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study.
Adams PC; Reboussin DM; Leiendecker-Foster C; Moses GC; McLaren GD; McLaren CE; Dawkins FW; Kasvosve I; Acton RT; Barton JC; Zaccaro D; Harris EL; Press R; Chang H; Eckfeldt JH
Clin Chem; 2005 Jun; 51(6):1048-52. PubMed ID: 15833784
[No Abstract] [Full Text] [Related]
17. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis.
Muckenthaler M; Roy CN; Custodio AO; Miñana B; deGraaf J; Montross LK; Andrews NC; Hentze MW
Nat Genet; 2003 May; 34(1):102-7. PubMed ID: 12704390
[TBL] [Abstract][Full Text] [Related]
18. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
19. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis.
Nicolas G; Viatte L; Lou DQ; Bennoun M; Beaumont C; Kahn A; Andrews NC; Vaulont S
Nat Genet; 2003 May; 34(1):97-101. PubMed ID: 12704388
[TBL] [Abstract][Full Text] [Related]
20. Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation.
Thorstensen K; Kvitland MA; Irgens WØ; Hveem K; Asberg A
Scand J Clin Lab Invest; 2010 Apr; 70(2):92-7. PubMed ID: 20073670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
